🧠 Understanding Leptomeningeal Metastatic Disease (LMD) In this video, Dr. Alireza Mansouri’s AI avatar explains how LMD develops, how it’s diagnosed, and the promising treatments and clinical trials shaping care in 2025. At WeTrials, we believe knowledge and access can change

🚨 🧬✨ A recent Phase II/III clinical trial, published on PubMed (PMID: 40779733), delved into the potential of immunotherapy for patients with MGMT unmethylated glioblastoma—a challenging subset of this aggressive brain cancer. 🧠💉 The study aimed to uncover whether

🚨 New study shows GLP-1 drugs like Ozempic may slash #meningioma brain tumor risk by up to 31% in obese adults! They looked at health records of 1000s of patients with and without drug, matching them for certain variables. jamanetwork.com/journals/jamao… 📉 Overall cancer risk down

🧠 Brain metastases in lung cancer: a frontier long ignored. Up to 40% of patients with EGFR-mutant non-small cell lung cancer (NSCLC) develop brain metastases. Yet historically, these patients are excluded from clinical trials—due to concerns about poor prognosis and the

REBECCA IS HOME. After a lengthy ordeal, Rebecca is home where she belongs. Our road is still long. Incredibly rocky with so many physical and mental health challenges. But somehow I will persevere. I'm very exhausted. I'll post a video later to explain where we are-and what

🚀 A big step forward in making clinical trials more inclusive. The ACHIEVE trial challenges the old narrative—showing that targeted systemic therapy can control untreated brain metastases in EGFR-mutant lung cancer without surgery or radiation. Just a pill. 💊 At WeTrials, we

💡 Emerging science shows how treatments designed for one purpose can reveal unexpected benefits. This large study suggests GLP-1 receptor agonists (like Ozempic/Wegovy), commonly used for weight loss, may also lower cancer risk — including reductions in endometrial, ovarian,

Thrilled to announce our team's latest publication! 🎉 Leveraging an extensive review of existing literature alongside our comprehensive database of 1,904 non-small cell #lungcancer (NSCLC) patients, we've identified and validated key clinical predictors for the development of

We had anecdotally noticed a drop in rate of melanoma brain metastases over the years, since the implementation of immunotherapy. This investigation suggests potential prophylactic role of dual agent IT, particularly driven by PD1 blockers. aacrjournals.org/clincancerres/…

🚨 Exciting news on the horizon for glioblastoma fighters! Danish company Curasight is gearing up to launch a Phase 1 trial for uTREAT, their targeted radiopharmaceutical, likely starting in Europe Q4 2025. Full details pending EMA green light. 🧠💉 uPAR is a protein that's

💛 This Childhood Cancer Awareness Month, we stand with brave young fighters and their families. Every child deserves access to hope and healing. 💛 At WeTrials, we're committed to connecting families with life-changing clinical trial opportunities through our comprehensive

The struggle of cancer recovery is an incredible dichotomy. I'm nearly one month into remission from stage 4 melanoma (for the third time). My prognosis is good, my physical health is trending fantastically, I have a great support and life setup, and... I'm floundering mentally

#ACHIEVE trial described in video format. #brainmetastases #BTSM National Brain Tumor Society American Brain Tumor Association WeTrials MansouriLab

Prior post: x.com/DrAMansouri/st…

Important insights shared on the ACHIEVE trial in EGFR+ NSCLC with brain metastases. This Phase 2 study tested high-dose aumolertinib—showing that targeted systemic therapy can control brain mets without WBRT or surgery. At 12 months, 72% of baseline brain tumors had no

🧠 Breaking down the latest in treating leptomeningeal disease (LMD) – where cancer invades the brain and spine's protective layers! This phase 2 trial compared proton craniospinal irradiation (CSI) vs. standard photon-involved field radiotherapy (IFRT). Proton CSI

🧠Yet another study on commonly administered meds and meningiomas! #Meningiomas are tumors that develop from the meninges—the protective layers around your brain and spinal cord. They're often benign but can press on nearby structures, causing headaches, seizures, or vision

We’re at the ABTA National Conference! Stop by our booth and discover how the ABTA Study Finder powered by WeTrials helps patients and caregivers: 🔍 Search for relevant clinical trials: abta.org/about-brain-tu… 📍 Filter by location and condition 💌 Connect directly with

💛 Childhood cancers aren’t just “smaller” adult cancers. They develop differently, grow faster, and need treatments designed for growing bodies. 📌 Pediatric cancers often arise from genetic changes during development — not lifestyle factors. 📌 Each type needs specialized

Caregiver Chronicles | Episode 4 How to Select Clinical Trials Every medical breakthrough starts with a clinical trial — the bridge between discovery and real-world treatment. 🌉 In this episode, care partner advisor Janet Fanaki shares practical guidance on how caregivers can